Pacific Biosciences of California, Inc.
PACB· Nasdaq
PACBPacific Biosciences of California, Inc.
Released Nov 4, 2016, after the close
10-Q filed Nov 4, 2016, 35 days after period end · 0001299130-16-000245
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q3 2016 | Q3 2015 | Q3 2014 | Q3 2013 |
|---|---|---|---|---|
| Revenue | $25.12M | $13.92M | $20.62M | $7.42M |
| Net Income | -$17.49M | $1.82M | -$9.16M | -$20.49M |
| EPS Diluted | -$0.19 |
Pacific Biosciences of California, Inc. · CIK 1299130 · Engraved from SEC EDGAR
| $0.02 |
| -$0.13 |
| -$0.31 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
